Rand Paul hits 'Biden/Harris CDC' over COVID-19 vaccine guidance for 6-month-olds [FOX News]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: FOX News
The Centers for Disease Control and Prevention's (CDC's) 2024-2025 COVID-19 vaccine immunization schedule advises, in the case of the 2024-2025 Pfizer-BioNTech vaccine, three doses for children ages 6 months old through 4 years old — and Sen. Rand Paul has suggested that such guidance is leading to public hesitancy to trust the agency's recommendations. "Pfizer drug reps…Uh, I mean, the Biden/Harris CDC, insists your 6-month-old get 3 COVID vaccines despite no scientific studies demonstrating decreased hospitalization or death. Is anyone surprised that the public is now hesitant to believe ANY CDC recommendations?" the lawmaker posted. Regarding the 2024-2025 Pfizer-BioNTech COVID-19 vaccine , the CDC's vaccine schedule suggests previously unvaccinated children in the 6-month through 4-year-old age bracket should receive an initial dose, followed by another "at least 3–8 weeks after Dose 1," and a third "at least 8 weeks after Dose 2." "An 8-week interval between the first and
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Is Pfizer (NYSE:PFE) a High-Yielding Dividend Stock Worth Buying? [Yahoo! Finance]Yahoo! Finance
- Is Moderna (NASDAQ:MRNA) Stock a Buy at Current Levels? [Yahoo! Finance]Yahoo! Finance
- 3 Stocks to Buy Following Robust Quarterly Results [Yahoo! Finance]Yahoo! Finance
- GSK dips as lower vaccine sales weigh on Q3 2024 results [Seeking Alpha]Seeking Alpha
- Why Pfizer Stock Tumbled on Tuesday [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 10/29/24 - Beat
PFE
Sec Filings
- 10/31/24 - Form 4
- 10/29/24 - Form 8-K
- 10/16/24 - Form 4
- PFE's page on the SEC website